Purpose. To evaluate the effectiveness of the developed method for preventing cicatricial fusion of dacryostomy (DS) after endonasal endoscopic dacryocystorhinostomy. Material and methods. The study included 58 patients (58 eyes) with chronic purulent dacryocystitis who underwent endonasal endoscopic dacryocystorhinostomy. All patients were divided into 2 groups: the main group (29 people) – at the final stage of the operation, a glove turunda was installed between the middle nasal concha and the cavity of the lacrimal sac under the control of a rhinoscope; comparisons (29 people) – they underwent surgical treatment according to standard technology. The criteria for evaluating the effectiveness of surgical treatment was the study of active and passive patency of the formed lacrimal ducts. Turunda was removed 6–7 days after surgery in patients of the main group and fibrinous clots in the area of the formed anastomosis in patients of the comparison group. Results. One month after the operation, all patients of the main group and the vast majority of patients (27 people – 93 %) of the comparison group showed good patency of the formed anastomosis. While 2 people of the comparison group (7 %) had contact between the DS mucosa and the middle turbinate, which led to the formation of a cicatricial strand of the “web” type and a recurrence of the disease by 3 months after the operation. In the period of 6 months, these patients were operated again. Conclusion. The developed method for the prevention of cicatricial fusion of DS using glove turunda after surgical treatment of dacryocystitis is an effective way to restore and maintain the full function of lacrimal drainage through natural pathways with a follow-up period of 12 months. Keywords: dacryostomy, infection prevention, chronic suppurative dacryocystitis.